CompoAtlas

Epaplus Arthicare Maintenance Instant arôme vanille

Food supplement declared in France, declaration No 2023-4-562, decision dated 13 April 2023

Epaplus Arthicare Maintenance Instant arôme vanille (Epaplus) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Epaplus
Food business operator placing the product on the market
Peroxfarma, S.A.
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Poudre
Daily dose
10,89 g
Directions for use
Prendre une mesure de Epaplus Arthicare dissous dans de l'eau, du jus ou un autre liquide (250 ml).
Not recommended for (according to the manufacturer)
Enfants (moins de 12 ans), Maladie rénale
Objectives stated by the manufacturer (these are not authorised claims)
Articulations
Flavourings
Vanille

Declaration 242690, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Bambusa bambos (L.) VossTigeAutre extrait sec57.2 mg

Other active ingredients

NamePer day
Collagène hydrolysénot declared
Hyaluronate de sodiumnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Carbonate de magnésiumMagnésium250 mg300 mg
Chlorhydrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
RiboflavineVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
L-ascorbate de calciumVitamine Cpas de limite (données insuffisantes)180 mg

Additives

E330, E955

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Les compléments alimentaires ne doivent pas être utilisés comme substitut d'un régime alimentaire équilibré. Ne pas dépasser la dose journalière expressément recommandée. Tenir hors de portée des jeunes enfants. Conserver hermétiquement fermé dans un endroit frais et sec. Il est recommandé aux personnes devant suivre un régime pauvre en protéines ou souffrant d'insuffisance rénale de consulter un médecin.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Collagène hydrolysé
    Read the warning, when it applies and the studies cited

    Hydrolyzed Collagen

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Joint pain.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Applies to products providing more than 2.8 g hydrolyzed collagen, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Shils et al. 2006; Goldman and Ausiello 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    When using this product you may experience gastrointestinal discomfort/disturbances (Moskowitz 2000).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 March 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Epaplus

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line